FOXN3 and thyroid gland papillary carcinoma: Zhao et al. reported that decreased FOXN3 expression was observed in papillary thyroid cancer and discovered that FOXN3 inhibited tumor cell growth and invasion via the inactivation of Wnt/ β-catenin pathway [13].